AnPac Bio Reports 49.1% Decrease in Net Loss in First Quarter of Fiscal 2022
PHILADELPHIA, May 31, 2022 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United...
View ArticleAnPac Bio Regains Compliance with Requirements to Remain Listed on Nasdaq...
AnPac Bio Regains Compliance with Requirements to Remain Listed on Nasdaq Capital Market Philadelphia, PA, June 10, 2022 – AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”)...
View ArticleAnPac Bio Approved Written Resolutions of a Majority of the Members...
AnPac Bio Approved Written Resolutions of a Majority of the Members Addressing the Removal of Directors and Officers, Re-designation of Officers, and Change of Members of the Committees Philadelphia,...
View ArticleAnPac Bio Announces Appointment of New Directors and Co-Chief Executive Officer
AnPac Bio Announces Appointment of New Directors and Co-Chief Executive Officer Philadelphia, PA, August 5, 2022 – AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a...
View ArticleAnPac Bio-Medical Sciences Announces Receipt of Staff Delisting Determination...
AnPac Bio-Medical Sciences Announces Receipt of Staff Delisting Determination from Nasdaq; Intends to Appeal Philadelphia, PA, September 12, 2022 – AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the...
View ArticleAnPac Bio Appeals NASDAQ Delisting Notice; Hearing Granted and Scheduled for...
AnPac Bio Appeals NASDAQ Delisting Notice; Hearing Granted and Scheduled for October 20, 2022 Philadelphia, PA, September 19, 2022 – AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or...
View ArticleAnPac Bio and New Investor Group Sign Equity Investment Totaling $3.67 Million
AnPac Bio and New Investor Group Sign Equity Investment Totaling $3.67 Million Philadelphia, PA, September 26, 2022 – AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a...
View ArticleAnPac Bio Announces Board and Management Changes
AnPac Bio Announces Board and Management Changes Philadelphia PA, October 3, 2022 – AnPac Bio-Medical Science Co., Ltd. (Nasdaq: ANPC) (“AnPac Bio” or the “Company”), a biotechnology company with...
View Article--- Article Not Found! ---
*** *** *** RSSing Note: Article is missing! We don't know where we put it!!. *** ***
View Article--- Article Not Found! ---
*** *** *** RSSing Note: Article is missing! We don't know where we put it!!. *** ***
View Article
More Pages to Explore .....